Statement of Ownership (sc 13g)
October 30 2020 - 9:08AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. ___)
CANCER GENETICS, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.0001
(Title of Class of Securities)
13739U203
(CUSIP Number)
October 28, 2020
(DATE OF EVENT WHICH REQUIRES FILING OF
THIS STATEMENT)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
|
*
|
The remainder of this cover page shall be filled out for
a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter the disclosures provided in a prior cover page.
|
The information required in the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
(Continued on following page(s)
Page 1 of 5 Pages
CUSIP No. 13739U203
|
13G
|
Page 2 of 5 Pages
|
1.
|
NAMES
OF REPORTING PERSON
|
|
S.S.
OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
|
|
|
Alpha
Capital Anstalt
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
|
(a)
☐
|
|
(b)
☐
|
3.
|
SEC
USE ONLY
|
|
|
|
|
4.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|
|
|
Liechtenstein
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
|
5.
|
SOLE VOTING POWER, – 227,272 Shares (1)
|
|
|
6.
|
SHARED VOTING POWER - None
|
|
|
7.
|
SOLE DISPOSITIVE POWER – 227,272 Shares (1)
|
|
|
8.
|
SHARED DISPOSITIVE POWER – None
|
|
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY
OWNED BY EACH REPORTING PERSON -
|
|
|
|
227,272 Shares (1)
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
|
|
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
|
|
|
5.87%
|
12.
|
TYPE OF REPORTING PERSON
|
|
|
|
CO
|
|
(1)
|
Based on 3,870,155 shares outstanding as of October 28,
2020 as reported in the FWP filed on October 29, 2020.
|
CUSIP No. 13739U203
|
13G
|
Page 3 of 5 Pages
|
|
ITEM 1 (a)
|
NAME OF ISSUER: Cancer Genetics, Inc.
|
|
ITEM 1 (b)
|
ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:
|
201 Route 17 North, 2nd Floor,
Rutherford, NJ 07070
|
ITEM 2 (a)
|
NAME OF PERSON FILING: Alpha Capital Anstalt
|
|
ITEM 2 (b)
|
ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
|
Lettstrasse 32, FL-9490 Vaduz, Furstentums,
Liechtenstein
|
ITEM 2 (c)
|
CITIZENSHIP: Liechtenstein
|
|
ITEM 2 (d)
|
TITLE OF CLASS OF SECURITIES: Common Stock, par value $0.0001
|
|
ITEM 2 (e)
|
CUSIP NUMBER: 13739U203
|
|
ITEM 3
|
IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR
13D-2(B):
|
Not applicable
|
(a)
|
AMOUNT BENEFICIALLY OWNED: 227,272 Shares (1)
|
|
(b)
|
PERCENT OF CLASS: 5.87%
|
|
(c)
|
NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
|
|
(i)
|
SOLE POWER TO VOTE OR DIRECT THE VOTE
|
227,272 Shares (1)
|
(ii)
|
SHARED POWER TO VOTE OR DIRECT THE VOTE
|
0 Shares
|
(iii)
|
SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION
OF
|
227,272 Shares (1)
|
(iv)
|
SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION
OF
|
0 Shares
CUSIP No. 13739U203
|
13G
|
Page 4 of 5 Pages
|
|
ITEM 5
|
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
|
Not applicable
|
ITEM 6
|
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON
|
Not applicable
|
ITEM 7
|
IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
|
Not applicable
|
ITEM 8
|
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP
|
Not applicable
|
ITEM 9
|
NOTICE OF DISSOLUTION OF GROUP
|
Not applicable
CUSIP No. 13739U203
|
13G
|
Page 5 of 5 Pages
|
SIGNATURE
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
October 29, 2020
|
|
(Date)
|
|
|
|
/s/ Konrad Ackermann
|
|
(Signature)
|
|
|
|
Konrad Ackermann, Director
|
|
(Name/Title)
|
Cancer Genetics (NASDAQ:CGIX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cancer Genetics (NASDAQ:CGIX)
Historical Stock Chart
From Sep 2023 to Sep 2024